Rifaximin (Xifaxan 550) for hepatic encephalopathy

Med Lett Drugs Ther. 2010 Nov 1;52(1350):87.
No abstract available

MeSH terms

  • Administration, Oral
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / economics
  • Anti-Bacterial Agents / therapeutic use*
  • Drug Administration Schedule
  • Drug Costs
  • Hepatic Encephalopathy / drug therapy*
  • Humans
  • Recurrence
  • Rifamycins / administration & dosage
  • Rifamycins / adverse effects
  • Rifamycins / economics
  • Rifamycins / therapeutic use*
  • Rifaximin
  • Tablets
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Rifamycins
  • Tablets
  • Rifaximin